Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern

Cell Res. 2022 Jan;32(1):103-106. doi: 10.1038/s41422-021-00590-x. Epub 2021 Nov 23.

Jingwen Ai^#¹, Haocheng Zhang^#¹, Qiran Zhang^#¹, Yi Zhang^#¹, Ke Lin¹, Zhangfan Fu¹, Jieyu Song¹, Yuanhan Zhao¹, Mingxiang Fan¹, Hongyu Wang¹, Chao Qiu¹, Yang Zhou¹, Wenhong Zhang^{2

3

4}

¹ Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
² Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. zhangwenhong@fudan.edu.cn.
³ National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China. zhangwenhong@fudan.edu.cn.
⁴ Key Laboratory of Medical Molecular Virology (MOE/MOH) Shanghai Medical College, Fudan University, Shanghai, China. zhangwenhong@fudan.edu.cn.

^# Contributed equally.

No abstract available

Publication types